AGL 40.18 Increased By ▲ 0.18 (0.45%)
AIRLINK 127.48 Increased By ▲ 0.44 (0.35%)
BOP 6.60 Decreased By ▼ -0.07 (-1.05%)
CNERGY 4.50 Decreased By ▼ -0.01 (-0.22%)
DCL 8.53 Decreased By ▼ -0.02 (-0.23%)
DFML 41.90 Increased By ▲ 0.46 (1.11%)
DGKC 87.56 Increased By ▲ 0.71 (0.82%)
FCCL 32.52 Increased By ▲ 0.24 (0.74%)
FFBL 65.21 Increased By ▲ 0.41 (0.63%)
FFL 10.30 Increased By ▲ 0.05 (0.49%)
HUBC 109.62 Increased By ▲ 0.05 (0.05%)
HUMNL 14.60 Decreased By ▼ -0.08 (-0.54%)
KEL 5.12 Increased By ▲ 0.07 (1.39%)
KOSM 7.56 Increased By ▲ 0.10 (1.34%)
MLCF 41.66 Increased By ▲ 0.28 (0.68%)
NBP 59.89 Decreased By ▼ -0.52 (-0.86%)
OGDC 194.00 Increased By ▲ 3.90 (2.05%)
PAEL 28.21 Increased By ▲ 0.38 (1.37%)
PIBTL 7.77 Decreased By ▼ -0.06 (-0.77%)
PPL 151.82 Increased By ▲ 1.76 (1.17%)
PRL 26.50 Decreased By ▼ -0.38 (-1.41%)
PTC 16.11 Increased By ▲ 0.04 (0.25%)
SEARL 84.80 Decreased By ▼ -1.20 (-1.4%)
TELE 7.70 Decreased By ▼ -0.01 (-0.13%)
TOMCL 35.39 Decreased By ▼ -0.02 (-0.06%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.03 Decreased By ▼ -0.38 (-2.32%)
TRG 52.60 Decreased By ▼ -0.69 (-1.29%)
UNITY 26.30 Increased By ▲ 0.14 (0.54%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,953 Increased By 69.4 (0.7%)
BR30 30,908 Increased By 307.7 (1.01%)
KSE100 93,785 Increased By 429.6 (0.46%)
KSE30 29,050 Increased By 119.3 (0.41%)

Scientists in the United States say they have taken a step toward developing a possible diagnostic test for chronic fatigue syndrome, a condition characterized by exhaustion and other debilitating symptoms. Researchers at Stanford University School of Medicine said a pilot study of 40 people, half of whom were healthy and half of whom had the syndrome, showed their potential biomarker test correctly identified those who were ill.
Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis or ME, is estimated to affect some 2.5 million people in the United States and as many as 17 million worldwide. Symptoms include overwhelming fatigue, joint pain, headaches and sleep problems. No cause or diagnosis has yet been established and the condition can render patients bed- or house-bound for years.
The research, published in the journal Proceedings of the National Academy of Sciences on Monday, analyzed blood samples from trial volunteers using a "nanoelectronic assay" - a test that measures changes in tiny amounts of energy as a proxy for the health of immune cells and blood plasma.
The scientists "stressed" the blood samples using salt, and then compared the responses. The results, they said, showed that all the CFS patients' blood samples creating a clear spike, while those from healthy controls remained relatively stable.
"We don't know exactly why the cells and plasma are acting this way, or even what they're doing," said Ron Davis, a professor of biochemistry and of genetics who co-led the study.
"But we clearly see a difference in the way healthy and chronic fatigue syndrome immune cells process stress."
Other experts not directly involved in this work cautioned, however, that its findings showed there is still a long way to go before a biomarker is found that can establish CFS diagnosis and distinguish it from other conditions with similar symptoms.

Copyright Reuters, 2019

Comments

Comments are closed.